Jean-Yves Douillard MD, PhD
Professor Emeritus, Medical Oncology, University of Nantes; Senior Advisor, Integrated Centers of Oncology (ICO), Nantes, FranceDr. Jean-Yves Douillard is a leading international expert in lung cancer and gastrointestinal oncology, and, over the course of a long career, he has held a number of leadership positions, including at the University of Nantes, where he was Professor in Medical Oncology, and at the Integrated Centers of Oncology (ICO) in Nantes, as Head of the Medical Oncology Department and later as Director of Clinical and Translational Research. He has also held senior ESMO positions, serving as Educational Committee Chair and as a member of the Executive Board.
Throughout his career, Dr. Douillard has led clinical trials in lung cancer and gastrointestinal tumors and has investigated targeted therapies, publishing his work in leading scientific journals. His clinical interests also include early drug development and translational research.
Currently, Dr. Doullard is serving as Senior Advisor in early clinical trial research at the Integrated Centers of Oncology.
Recent Contributions to PracticeUpdate:
- Practice Impact of Key NSCLC Trials at ESMO 2017
- ESMO 2016: A Grand Cru
- Dr. Jean-Yves Douillard Appointed ESMO's First CMO
- Routine Molecular Profiling of Patients With Advanced Non–Small Cell Lung Cancer
- Bevacizumab for Newly Diagnosed Pleural Mesothelioma
- Pembrolizumab vs Docetaxel for Previously Treated, PD-L1–Positive, Advanced Non–Small Cell Lung Cancer
- ESMO Asia 2015: Dr. Jean-Yves Douillard on LUX-Lung 7 and KEYNOTE-010
- 2015 Top Stories in Oncology: Lung Cancer
- ECC 2015 Recap: Non–Small Cell Lung Cancer Recommendations From Dr. Jean-Yves Douillard
- ECC 2015 Recap: Small Cell Lung Cancer Recommendations From Dr. Jean-Yves Douillard